Revisiting Screening in Women With a Family History of Breast Cancer.
breast cancer
contrast-enhanced mammography
familial risk
magnetic resonance imaging (MRI)
mammography
screening
ultrasound
Journal
Journal of breast imaging
ISSN: 2631-6129
Titre abrégé: J Breast Imaging
Pays: United States
ID NLM: 101752190
Informations de publication
Date de publication:
30 Nov 2023
30 Nov 2023
Historique:
received:
31
05
2023
medline:
23
12
2023
pubmed:
23
12
2023
entrez:
23
12
2023
Statut:
ppublish
Résumé
Women with a family history (FH) of breast cancer and without known genetic susceptibility represent a unique population whose lifetime probability of developing breast cancer varies widely depending on familial factors, breast density, and the risk assessment tool used. Recently updated guidelines from the American College of Radiology recommend supplemental annual screening with contrast-enhanced MRI or contrast-enhanced mammography for women with an FH who are high risk (≥20% lifetime risk) or have dense breasts. To date, most screening studies addressing outcomes in women with FH have largely included those also with confirmed or suspected gene mutations, in whom the lifetime risk is highest, with limited data for women at average to intermediate risk who are not known to be genetically susceptible and may not benefit as much from the same screening approaches. Further research focusing specifically on women with FH as the only breast cancer risk factor is warranted to refine risk assessment and optimize a multimodality personalized screening approach.
Identifiants
pubmed: 38141237
pii: 7329706
doi: 10.1093/jbi/wbad069
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
635-645Informations de copyright
© Society of Breast Imaging 2023. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.